# OceansBio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oceansbio

- Industry: Healthcare IT
- Headquarters: Changwon-si,, South Korea
- Website: www.oceansbio.com
- Latest round: Seed (Sep 1, 2021)
- Investors on record: 2

## About

Founded in 2018, and based in Gyeongsangnam-do, South Korea, OceansBio Co., Ltd. operates as a healthcare IT developer that develops an AI-based electroceutical solution for epilepsy treatment. In May 2023, OceansBio Co., Ltd. raised pre-series A funding from new investors Seoul Technology Holdings, Pusan National University Technology Holdings, Korea Credit Guarantee Fund, and D.CAMP. Financial terms of the deal were not disclosed. The company will use the  May funding to spur prototype development and clinical trials of electronic drugs for depression and epilepsy, as well as expand and commercialize its technology platform targeting various conditions.

## Funding rounds

- Seed, Sep 1, 2021 — Korea Tech Incubator for Startup, The Ventures

## Investors

- Korea Tech Incubator for Startup — Seed
- The Ventures (https://capitalatlas.ai/funds/the-ventures) — Seed